One-third of hepatitis C prescriptions receive absolute denial from insurers

One-third of hep C rx receive absolute denial from insurers

(HealthDay)—Insurers are increasingly denying prescriptions of direct-acting antiviral (DAA) drugs for hepatitis C virus treatment, according to a study published online June 7 in Open Forum Infectious Diseases.

Charitha Gowda, M.D., M.P.H., from The Ohio State University in Columbus, and colleagues analyzed data from 9,025 patients (from 45 states) who had a DAA prescription submitted from January 2016 to April 2017 to Diplomat Pharmacy, Inc., which provides hepatitis C virus pharmacy services across the United States. The authors sought to determine the rate of absolute denial of DAA prescription, defined as lack of fill approval by the insurer. Rates were determined by payer type.

The researchers found that there were 3,200 absolute denials (35.5 percent). Denials were more common among patients covered by commercial insurance (52.4 percent) versus Medicaid (34.5 percent) or Medicare (14.7 percent). Each quarter, the incidence of absolute denial increased across the study period, overall (range: 27.7 percent in first quarter versus 43.8 percent in last quarter).

"Eliminating hepatitis C in the United States is a feasible goal, but that's going to be hard to achieve if payers are not reimbursing for the treatment," a coauthor said in a statement.

Two authors disclosed financial ties to Gilead Sciences.

2018 World Hepatitis Day is Saturday, July 28.


Explore further

Insurance denials for new hepatitis C drugs remain high nationwide, study suggests

More information: Abstract/Full Text
World Hepatitis Day

Copyright © 2018 HealthDay. All rights reserved.

Citation: One-third of hepatitis C prescriptions receive absolute denial from insurers (2018, July 26) retrieved 23 July 2019 from https://medicalxpress.com/news/2018-07-one-third-hepatitis-prescriptions-absolute-denial.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Jul 26, 2018
Please share the information that saved my life and thousands of us. Safe, identical generics of hep C meds can be imported for personal use. Humanitarian Australian doctor, James Freeman, has set up a "buyers club ' model, FixhepC.com to help people do it safely. He is widely published and acclaimed. I'm a law student, advocate and volunteer. This is for real. Disrupt the pharma prices, push back. Medical Express, contact me-you really should do a story on this. You would save lots of lives.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more